Bloomberg News reported that
GlaxoSmithKline P.L.C. has agreed to pay $1 billion to injured consumers to resolve more than
800 cases involving the antidepressantPaxil. The medication has been in use in the U.S. since 1992. Paxil generated
about $793 million in sales in 2009 alone which was about 1.8 percent
of Glaxo’s total revenue. Glaxo reported U.S. sales exceeding $11
billion since 1997.
Not all of the pending birth defect cases are resolved, according to the
report, about 100 Paxil claims are not included in this settlement. Glaxo
confirmed that it settled some Paxil cases citing the reason as avoiding
costs and uncertainties of litigation, but would not comment on the terms
of the settlement. A Philadelphia jury awarded a 3 year old boy $2.5 million
finding that Paxil caused severe heart defects in a trial in October of
About the author:
Catherine Bertram is board certified in civil trials and was recently nominated as a 2010
Super Lawyer for Washington, D.C. Ms. Bertram has 20 years of trial
experience and is unique in that she was formerly the Director of Risk Management
for Georgetown University Hospital. Ms. Bertram is a member of the bar
for the U.S. Supreme Court. She is a partner with the firm and lectures
regularly to lawyers and health care providers, nationally and locally,
regarding patient safety, medical negligence and other related issues.
She has also recently published a chapter in a surgical textbook. She
can be reached by email at firstname.lastname@example.org or by phone 202-822-1875
in her office in Washington, D.C.